Born as a second Manhattan Project, the Trump administration vaccine program actually achieved most of its goals – until distribution problems marred its success.
Related posts:
FDA authorizes third dose of Pfizer, Moderna shots for immunocompromised
Scalise warns shaming won’t help boost vaccinations
Troubling CDC vaccine data convinced Biden team to back booster shots
Centrists throw wrench in House Democrats’ drug pricing plans
DeSantis flirts with the anti-vaccine crowd
Confusion over Biden’s booster plan riles governors
Collins, Fauci endorse and explain FDA’s recommendation for limited use of boosters
Pfizer and BioNTech ask FDA to approve their Covid-19 vaccine for kids as young as 12
Bad Covid winter brings questions about what’s ‘fully vaccinated’
‘A lot of money on the table’: Fight brews over surprise medical bills
Abortion pill fight could ensnare Biden’s FDA pick
CDC: Vaccinated Americans with a prior infection fared the best during Delta
